Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Geva

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Harefuah|September 1, 1993
[Comparison of ovulation induction protocols for in vitro fertilization]E Geva, I Yovel, J B Lessing, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|February 1, 1997
Interleukin-10 in preovulatory follicular fluid of patients undergoing in-vitro fertilization and embryo transferE Geva, J B Lessing, L Lerner-Geva, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|April 4, 1998
High levels of anticardiolipin antibodies in patients with abnormal embryo morphology who attended an in vitro fertilization programF Azem, E Geva, A Amit, et al.
Genetic Testing|January 6, 2001
The risk of fragile X premutation expansion is lower in carriers detected by general prenatal screening than in carriers from known fragile X familiesE Geva, Y Yaron, R Shomrat, et al.
Fertility and Sterility|December 11, 1999
Levels of vascular endothelial growth factor are elevated in patients with ectopic pregnancy: is this a novel marker?Y Daniel, E Geva, L Lerner-Geva, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|March 4, 2000
Prednisone and aspirin improve pregnancy rate in patients with reproductive failure and autoimmune antibodies: a prospective studyE Geva, A Amit, L Lerner-Geva, et al.
Human Reproduction (Oxford, England)|August 1, 1996
Organ-specific autoantibodies are possible markers for reproductive failure: a prospective study in an in-vitro fertilization-embryo transfer programmeE Geva, N Vardinon, J B Lessing, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Harefuah|September 1, 1993
[Comparison of ovulation induction protocols for in vitro fertilization]E Geva, I Yovel, J B Lessing, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|February 1, 1997
Interleukin-10 in preovulatory follicular fluid of patients undergoing in-vitro fertilization and embryo transferE Geva, J B Lessing, L Lerner-Geva, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|April 4, 1998
High levels of anticardiolipin antibodies in patients with abnormal embryo morphology who attended an in vitro fertilization programF Azem, E Geva, A Amit, et al.
Genetic Testing|January 6, 2001
The risk of fragile X premutation expansion is lower in carriers detected by general prenatal screening than in carriers from known fragile X familiesE Geva, Y Yaron, R Shomrat, et al.
Fertility and Sterility|December 11, 1999
Levels of vascular endothelial growth factor are elevated in patients with ectopic pregnancy: is this a novel marker?Y Daniel, E Geva, L Lerner-Geva, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|March 4, 2000
Prednisone and aspirin improve pregnancy rate in patients with reproductive failure and autoimmune antibodies: a prospective studyE Geva, A Amit, L Lerner-Geva, et al.
Human Reproduction (Oxford, England)|August 1, 1996
Organ-specific autoantibodies are possible markers for reproductive failure: a prospective study in an in-vitro fertilization-embryo transfer programmeE Geva, N Vardinon, J B Lessing, et al.
Pageof 6